Pregnancy in Congenital Heart Disease:A Review for the General Cardiologist  

作　　者：Kathryn Patrick Arwa Saidi 

机构地区：[1]Department of Obstetrics and Gynecology,University of Florida,Gainesville,FL 32608,USA [2]Department of Pediatrics,University of Florida,Gainesville,FL 32608,USA [3]Department of Internal Medicine,University of Florida,Gainesville,FL 32608,USA

出　　处：《Cardiovascular Innovations and Applications》2018年第B05期31-39,共9页心血管创新与应用（英文）

摘　　要：Cardiovascular disease is the leading cause of pregnancy-related deaths in the United States[1].An estimated 4% of all pregnancies in the United States are affected by maternal cardiovascular disease,with 80% of these cases attributed to congenital heart disease(CHD)[2– 4].Secondary to improved diagnosis and management of CHD,more women with CHD are reaching reproductive age,and many of these women desire pregnancy.While many pregnant women with CHD will have an uncomplicated pregnancy and delivery,some with more complex cardiac lesions or comorbidities will have an increased risk of maternal and neonatal morbidity and death.Individualized preconception,antepartum,intrapartum.

关 键 词：PREGNANCY CARDIOVASCULAR disease MATERNAL FETAL medicine 

分 类 号：R[医药卫生]